Literature DB >> 30440635

Micro-Inversions In Human Cancer Genomes.

Li Qu, Huaiqiu Zhu, May Wang.   

Abstract

During the past few years, although scientists and researchers have studied variations in the cancer genomes, our current knowledge about the function of Micro-inversions (MIs) in cancer are still limited. MIs are generally defined as small inversions in DNA segments shorter than 100 bp. To expand our knowledge of their roles in cancer, we analyzed the MIs of 209 samples from four types of cancer, including hepatocellular carcinoma, lung cancer, pancreatic cancer, and bladder cancer. Within all the 209 samples, we identified 2,925 MIs, of which 1,519 (51.93%) are in gene regions. Of the 1,519 MIs in the gene regions, 106 (6.98%) are in the exon regions. We also analyzed 209 healthy samples as the control samples. We further analyzed the distribution of MIs in the four types of cancer among 24 chromosomes. Besides the chromosome preference, different cancers also have different preference for various genes. The MIs preference for different genes among four types of cancer may provide a guidance for the treatment and diagnosis on the four types of cancer. Medical doctors should concentrate more on chromosomes and the genes that MIs prefer to locate on. We also calculated the average count of MIs per individual among each cancer. From this result, we found that the bladder cancer has the most average count of MIs per individual, which means MIs may be more likely to exist in bladder cancer. According to our analysis, MIs play an important role in cancer and should be considered for further analysis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30440635      PMCID: PMC7339915          DOI: 10.1109/EMBC.2018.8512514

Source DB:  PubMed          Journal:  Annu Int Conf IEEE Eng Med Biol Soc        ISSN: 2375-7477


  17 in total

Review 1.  Structural variants: changing the landscape of chromosomes and design of disease studies.

Authors:  Lars Feuk; Christian R Marshall; Richard F Wintle; Stephen W Scherer
Journal:  Hum Mol Genet       Date:  2006-04-15       Impact factor: 6.150

2.  RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia.

Authors:  Elli Papaemmanuil; Inmaculada Rapado; Yilong Li; Nicola E Potter; David C Wedge; Jose Tubio; Ludmil B Alexandrov; Peter Van Loo; Susanna L Cooke; John Marshall; Inigo Martincorena; Jonathan Hinton; Gunes Gundem; Frederik W van Delft; Serena Nik-Zainal; David R Jones; Manasa Ramakrishna; Ian Titley; Lucy Stebbings; Catherine Leroy; Andrew Menzies; John Gamble; Ben Robinson; Laura Mudie; Keiran Raine; Sarah O'Meara; Jon W Teague; Adam P Butler; Giovanni Cazzaniga; Andrea Biondi; Jan Zuna; Helena Kempski; Markus Muschen; Anthony M Ford; Michael R Stratton; Mel Greaves; Peter J Campbell
Journal:  Nat Genet       Date:  2014-01-12       Impact factor: 38.330

Review 3.  Exploring the genomes of cancer cells: progress and promise.

Authors:  Michael R Stratton
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

Review 4.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

Review 5.  Molecular landscape of pancreatic cancer: implications for current clinical trials.

Authors:  Gregory M Heestand; Razelle Kurzrock
Journal:  Oncotarget       Date:  2015-03-10

6.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

7.  High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.

Authors:  Karol Czubak; Marzena Anna Lewandowska; Katarzyna Klonowska; Krzysztof Roszkowski; Janusz Kowalewski; Marek Figlerowicz; Piotr Kozlowski
Journal:  Oncotarget       Date:  2015-09-15

8.  Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.

Authors:  Zachary R Chalmers; Caitlin F Connelly; David Fabrizio; Laurie Gay; Siraj M Ali; Riley Ennis; Alexa Schrock; Brittany Campbell; Adam Shlien; Juliann Chmielecki; Franklin Huang; Yuting He; James Sun; Uri Tabori; Mark Kennedy; Daniel S Lieber; Steven Roels; Jared White; Geoffrey A Otto; Jeffrey S Ross; Levi Garraway; Vincent A Miller; Phillip J Stephens; Garrett M Frampton
Journal:  Genome Med       Date:  2017-04-19       Impact factor: 11.117

9.  Identifying micro-inversions using high-throughput sequencing reads.

Authors:  Feifei He; Yang Li; Yu-Hang Tang; Jian Ma; Huaiqiu Zhu
Journal:  BMC Genomics       Date:  2016-01-11       Impact factor: 3.969

10.  TNIK inhibition abrogates colorectal cancer stemness.

Authors:  Mari Masuda; Yuko Uno; Naomi Ohbayashi; Hirokazu Ohata; Ayako Mimata; Mutsuko Kukimoto-Niino; Hideki Moriyama; Shigeki Kashimoto; Tomoko Inoue; Naoko Goto; Koji Okamoto; Mikako Shirouzu; Masaaki Sawa; Tesshi Yamada
Journal:  Nat Commun       Date:  2016-08-26       Impact factor: 14.919

View more
  1 in total

1.  Characteristics and possible mechanisms of formation of microinversions distinguishing human and chimpanzee genomes.

Authors:  Nadezhda A Potapova; Alexey S Kondrashov; Sergei M Mirkin
Journal:  Sci Rep       Date:  2022-01-12       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.